CABA Stock Summary and Trading Ideas (Cabaletta Bio | NASDAQ:CABA)

Cabaletta Bio Inc is a clinical-stage biotechnology company focused on the discovery and development of engineered T cell therapies and exploring their potential to provide a deep and durable, perhaps curative, treatment for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes Chimeric AutoAntibody Receptor, or CAART cells, that are designed to selectively bind and eliminate only specific B cells that produce disease-causing autoantibodies, or pathogenic B cells, while sparing normal B cells. Its CABA platform encompasses two strategies: CARTA (chimeric antigen receptor T cells for autoimmunity) and CAART (chimeric autoantibody T cells) that have the potential to be applied across a broad range of autoimmune diseases.

Cabaletta Bio trades on the NASDAQ stock market under the symbol CABA.

As of March 24, 2026, CABA stock price declined to $2.67 with 1,621,299 million shares trading.

CABA has a beta of 3.75, meaning it tends to be more sensitive to market movements. CABA has a correlation of 0.27 to the broad based SPY ETF.

CABA has a market cap of $257.03 million. This is considered a Small Cap stock.

Last quarter Cabaletta Bio reported $0 in Revenue and -$.40 earnings per share. This fell short of revenue expectation by $-833,330 and exceeded earnings estimates by $.06.

In the last 3 years, CABA traded as high as $26.35 and as low as $.99.

The top ETF exchange traded funds that CABA belongs to (by Net Assets): VTI, VXF, IBB, IWC, PRFZ.

CABA has outperformed the market in the last year with a return of +53.4%, while the SPY ETF gained +17.1%. In the last 3 month period, CABA beat the market returning +22.5%, while SPY returned -4.8%. However, in the most recent 2 weeks CABA has underperformed the stock market by returning -18.3%, while SPY returned -3.4%.

CABA support price is $2.66 and resistance is $2.98 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CABA shares will trade within this expected range on the day.